In the realm of diagnostic medicine, certain tests have become ubiquitous, ordered almost instinctively by clinicians navigating the complexities of infectious diseases. Among these, the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) tests stand out, often ordered together to provide a semblance of diagnostic reassurance. However, as highlighted by Prof. Brad Spellberg and his colleagues in their recent publication, it’s time to confront the long-standing dogma surrounding these tests and reconsider their routine use.
The Reality Behind ESR and CRP
Over the past five years, numerous systematic reviews and meta-analyses have scrutinized the diagnostic accuracy of ESR and CRP for various infectious diseases. The findings are sobering: these tests, despite their widespread use, offer limited diagnostic utility. In orthopedic infections, the sensitivity and specificity of these tests hover between 52% to 83%, with likelihood ratios that are far from impressive. For example, in diagnosing diabetic foot infections without osteomyelitis, ESR showed a modest positive likelihood ratio of 4.8 but with wide confidence intervals and inconsistent diagnostic cut-offs, rendering it unreliable.
The situation is even more concerning when it comes to other infections. For conditions like pyelonephritis, pneumonia, and tuberculosis, the tests perform poorly, with low specificities that undermine their diagnostic value. The conclusion is clear: despite being routinely ordered, ESR and CRP are not the reliable indicators many believe them to be.
Beyond Accuracy: The Redundancy and Risk of Misdiagnosis
One of the critical issues with ESR and CRP is their redundancy in clinical practice. Often, these tests are ordered in patients who already exhibit clear signs of inflammation—such as fever or elevated white blood cell counts—where the additional information provided by ESR or CRP is negligible. In some cases, these tests may even contribute to diagnostic errors, leading to unnecessary treatments or prolonged hospital stays. For instance, a patient recovering well from gastroenteritis might be kept in the hospital due to an elevated CRP level, while another with a serious infection might be prematurely discharged due to a low CRP result.
Moreover, the lack of standardized cut-off values for these tests further complicates their interpretation. Different studies use varying thresholds, leaving clinicians in the dark about which cut-off to apply in practice. This variability only adds to the confusion and reduces the tests’ reliability.
Why Do We Still Use Them?
Given the overwhelming evidence against the routine use of ESR and CRP, one might wonder why these tests persist. The answer lies in their ease of use, low cost, and the psychological comfort they provide to clinicians facing diagnostic uncertainty. In a world where swift decision-making is often required, a simple test result that aligns with a clinician’s intuition can offer reassurance, even if it adds little to the clinical picture.
However, this convenience comes at a cost. The widespread use of these tests leads to unnecessary healthcare expenses, potential diagnostic errors, and the perpetuation of outdated medical practices. It’s a classic case of the “zombie test”—a test that continues to be ordered despite evidence of its ineffectiveness, driven by habit and the fear of missing something critical.
The Path Forward: Embracing Diagnostic Stewardship
The time has come to rethink our reliance on ESR and CRP. As Spellberg and colleagues argue, these tests should not be part of routine diagnostic processes for infections. Instead, we must embrace the principles of diagnostic stewardship—ensuring that the right test is ordered for the right patient at the right time, and that it prompts the right clinical action.
Efforts in Canada and other countries have shown that it is possible to curb the use of these tests without compromising patient care. By reducing unnecessary orders, we can free up resources, reduce healthcare costs, and, most importantly, improve patient outcomes.
Conclusion
ESR and CRP are relics of a bygone era in diagnostic medicine. As we move toward more precise and evidence-based practices, it’s time to let go of these zombie tests. By doing so, we can prevent ourselves from becoming diagnostic-test-ordering automatons and instead focus on what truly matters: providing the best possible care for our patients.
For a more detailed exploration of this topic, you can access the full study by Brad Spellberg and his colleagues here.
=
Leave a Reply